| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS20006104 | HPV | ENSG00000148408.15 | protein_coding | CACNA1B | No | No | 774 | Q00975 |
| TVIS20023849 | HPV | ENSG00000148408.15 | protein_coding | CACNA1B | No | No | 774 | Q00975 |
| TVIS44026220 | HTLV-1 | ENSG00000148408.15 | protein_coding | CACNA1B | No | No | 774 | Q00975 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | CACNA1B |
|---|---|
| DrugBank ID | DB00661 |
| Drug Name | Verapamil |
| Target ID | BE0002226 |
| UniProt ID | Q00975 |
| Regulation Type | inhibitor |
| PubMed IDs | 10385261 |
| Citations | Dobrev D, Milde AS, Andreas K, Ravens U: The effects of verapamil and diltiazem on N-, P- and Q-type calcium channels mediating dopamine release in rat striatum. Br J Pharmacol. 1999 May;127(2):576-82. doi: 10.1038/sj.bjp.0702574. |
| Groups | Approved |
| Direct Classification | Phenylbutylamines |
| SMILES | COC1=C(OC)C=C(CCN(C)CCCC(C#N)(C(C)C)C2=CC(OC)=C(OC)C=C2)C=C1 |
| Pathways | Verapamil Action Pathway |
| PharmGKB | PA451868 |
| ChEMBL | CHEMBL6966 |
